Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04503395 · ClinicalTrials.gov registry record · NA

ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

A NA study of Aortic Aneurysm, Abdominal, sponsored by FCRE (Foundation for Cardiovascular Research and Education).

Recruiting
Registry status
NA
Development phase
204
Enrollment target
20
Study locations

NCT04503395 is a NA study of Aortic Aneurysm, Abdominal that is actively recruiting participants, run by FCRE (Foundation for Cardiovascular Research and Education). The registered enrollment target is 204 participants, above the 129-participant average among 8 other Aortic Aneurysm, Abdominal trials with a reported enrollment target (58% higher). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04503395, a NA study of Aortic Aneurysm, Abdominal, is actively recruiting participants, sponsored by FCRE (Foundation for Cardiovascular Research and Education).

RECRUITING
Registry status
NA
Development phase
204 participants
Enrollment target
20
Study locations

Study Summary

The aim of this randomized study is to compare the safety and performance of EndoVascular Aneurysm Repair with ESAR using Endurant + Heli-FX™ EndoAnchor™ system and FEVAR using customizable grafts from Cook (Zenith Fenestrated Graft) and Terumo (Fenestrated Anaconda Graft) for the treatment of aortic aneurysms with short aortic neck (4 to 15mm).

Conditions Studied

Interventions

  • DEVICE ESAR treatment: Endograft + Heli-FX Endoanchor
  • DEVICE FEVAR treatment : Fenestrated endograft

Study Locations (20)

Other

  • Hospital Ottakring, Institute for Vascular Surgery - Vienna
  • CRC thoracic Vascular Surgery, ZOL Genk - Genk
  • Universitair Ziekenhuis Gent, Thoracale en vasculaire heelkunde - Ghent
  • Amrois Paré Hospital (APHP) - Boulogne
  • Service de Chirurgie Vasculaire et Endovasculaire CHU Gabriel-Montpied 58 rue Montalembert - Clermont-Ferrand
  • Hospices Civils de lyon - Hôpital Edouard Herriot - Lyon
  • Centre Hospitalier Universitaire de Rennes - Rennes
  • University Hospital RWTH Aachen - Aachen
  • University Hospital Leipzig - Leipzig
  • Martin Austermann - Münster

California

  • UCSD Medical Center Hillcrest - La Jolla
  • Stanford University - Stanford

Florida

  • University of Florida - Gainesville

Michigan

  • Corewell Health (Spectrum) - Grand Rapids

New York

  • Mount Sinai Hospital - New York

North Carolina

  • Atrium Health Carolinas Medical Center - Charlotte

Oklahoma

  • Oklahoma Heart - Tulsa

Oregon

  • Providence Portland Medical Center - Portland

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2021-05-21
Est. Completion 2028-06-01
Phase NA

What the Registry Record Tells You About NCT04503395

The ClinicalTrials.gov registry entry for NCT04503395 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 129-participant average among 8 other Aortic Aneurysm, Abdominal trials with a reported enrollment target (58% higher). The listed sponsor is FCRE (Foundation for Cardiovascular Research and Education), which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aortic Aneurysm, Abdominal appearing as the primary indexed condition, and to 2 interventions - of which ESAR treatment: Endograft + Heli-FX Endoanchor is the first listed.

NCT04503395 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Other, California, Florida.

Frequently Asked Questions

What is clinical trial NCT04503395 about?

NCT04503395 is a clinical study titled "ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES". The aim of this randomized study is to compare the safety and performance of EndoVascular Aneurysm Repair with ESAR using Endurant + Heli-FX™ EndoAnchor™ system and FEVAR using customizable grafts from Cook (Zenith Fenestrated Graft) and Terumo (Fenestrated Anaconda Graft) for the treatment of aorti...

What is the current status of trial NCT04503395?

This trial is currently recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2021-05-21. Estimated completion is 2028-06-01.

What conditions does trial NCT04503395 study?

This clinical trial studies the following conditions: Aortic Aneurysm, Abdominal.

What interventions are being tested in trial NCT04503395?

The interventions under investigation include: ESAR treatment: Endograft + Heli-FX Endoanchor (DEVICE), FEVAR treatment : Fenestrated endograft (DEVICE).

Who is sponsoring clinical trial NCT04503395?

This trial is sponsored by FCRE (Foundation for Cardiovascular Research and Education), which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04503395 being conducted?

This trial has 20 study locations across California, Florida, Michigan, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aortic Aneurysm, Abdominal

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.